XM does not provide services to residents of the United States of America.

Indian shares set to open little changed



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares set to open little changed</title></head><body>

BENGALURU, Aug 28 (Reuters) -Indian shares, which are a whisker away from record highs, are set to open little changed on Wednesday, with traders expecting further profit booking ahead of key macroeconomic data later this week.

The GIFT Nifty GIFc1 was trading at 25,002.5 as of 08:07 a.m. IST, indicating that the NSE Nifty 50 .NSEI will open near its previous close of 25,017.75.

The Nifty 50, which has added about 3.6% in nine sessions, its longest daily winning run in 16 months, came within five points of a record high on Tuesday, helped by surplus liquidity.

Foreign institutional investors (FII) remained net buyers of Indian shares for a fourth session in a row on Tuesday, purchasing shares worth 15.04 billion rupees ($179.2 million) on a net basis.

Domestic institutional investors (DII) were also buyers of Indian stocks for 15 sessions until Monday.

Profit taking in overheated segments of the markets will likely continue further, two traders said, adding that caution has set innear record high levels, ahead of domestic growth data and U.S. inflation readings, due later in the week.

Asian markets opened lower on the day, with the MSCI Asia ex-Japan index .MIAPJ0000PUS shedding 0.4%. Wall Street equities closed marginally higher overnight ahead of a much-anticipated quarterly report from Nvidia NVDA.O and U.S. economic data.[MKTS/GLOB]


STOCKS TO WATCH

** ICICI Prudential Life ICIR.NS gets tax order for demand of 4.29 billion rupees.

** PNC Infratech PNCI.NS declared as lowest bidder by NHAI for a projected worth 3.8 billion rupees.

** Zydus Lifesciences ZYDU.NS receives US drug regulator's approval for drug used for treatment of Parkison's disease.



($1 = 83.9350 Indian rupees)



Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sonia Cheema

</body></html>

Related Assets


Latest News

India stocks, rupee, swaps, call at 10:15 a.m. IST


UK Stocks-Factors to watch on Aug 28

B
G
U

Factors to watch - Aug 28

N

Poison pills will hurt Seven & i and Japan


Market held in thrall ahead of Nvidia numbers

E
G
N
U
U

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.